Giant antibody in humans acts like a brace against bacterial toxins
Protein L is known as a “superantigen” because it can bind antibodies in unusual ways
Protein L is known as a “superantigen” because it can bind antibodies in unusual ways
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
The technology offers scalable continuous granulation at 200 kg/hour, with the potential to exceed 500 kg/hour for certain granules
EBITDA stood at Rs. 100.1 crore with a margin of 16.1 per cent
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
The savings will be fully reinvested to support new product launches and its pipeline across multiple therapeutic areas
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Shelcal Total marks the brand’s evolution into a modern, consumer-focused nutrition portfolio
In collaboration with the Gates Foundation, Merck advances MK-8527 pre-exposure prophylaxis (PrEP) clinical trials globally
Subscribe To Our Newsletter & Stay Updated